GenSight Biologics S.A.
GSGTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $2 | $11 | $44 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $3 | $1 |
| Inventory | $0 | $0 | $8 | $4 |
| Other Curr. Assets | $3 | $4 | $0 | $4 |
| Total Curr. Assets | $5 | $7 | $23 | $53 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $0 |
| Tax Assets | $0 | $0 | -$1 | $0 |
| Other NC Assets | $4 | $1 | $1 | $1 |
| Total NC Assets | $5 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11 | $9 | $26 | $57 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $8 | $12 |
| Short-Term Debt | $14 | $17 | $2 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $4 | $5 |
| Total Curr. Liab. | $23 | $25 | $15 | $22 |
| LT Debt | $5 | $6 | $15 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $8 | $11 | $11 |
| Total NC Liab. | $15 | $15 | $27 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $2 |
| Total Liabilities | $38 | $40 | $41 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $197 | $0 | $138 |
| Common Stock | $3 | $2 | $1 | $1 |
| Retained Earnings | -$14 | -$26 | -$28 | -$29 |
| AOCI | -$223 | -$197 | -$170 | -$138 |
| Other Equity | $207 | -$6 | $181 | $43 |
| Total Equity | -$27 | -$31 | -$15 | $16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $11 | $9 | $26 | $57 |
| Net Debt | $17 | $21 | $7 | -$32 |